G6PD and small cell lung carcinoma: GSE31210 including 246 NSCLC samples was selected for further analysis, and patients with lower mRNA levels of G6PD were significantly associated with longer OS and relapse-free survival (RFS) than those with higher expression (Fig. S6A, B), demonstrating the unique role of G6PD in SCLC.